相关实验视频

Updated: Jun 13, 2025

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

在接受心血管重症监护病房的患者中,峰值托罗邦水平和预后之间的关联

Ranel Loutati¹, Sharon Bruoha², Louay Taha¹

¹Jesselson Integrated Heart Center, The Eisenberg R&D Authority, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel.

International journal of cardiology

|September 13, 2024

概括

高峰水平的高灵敏性心脏热素 (hs-cTn) 表示显著的心肌损伤,并与密集心血管护理单位的死亡率增加有关. 在STEMI和NSTEMI患者之间,预后值不同.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
密集护理医学密集护理医学

背景情况:

高灵敏度心脏托波素 (hs-cTn) 对于检测心肌损伤至关重要.
在密集心血管护理病房 (ICCU) 中hs-cTn的预后影响需要进一步阐明.
这项研究调查了hs-cTn峰值水平与ICCU环境中的患者结果之间的关联.

研究的目的:

评估高灵敏度心脏托罗邦素I (hs-cTnI) 水平的预后价值.
确定hs-cTnI水平与ICCU患者一年全因死亡率之间的关联.
根据hs-cTnI水平在心肌梗塞亚型之间探索死亡风险的差异.

主要方法:

预计将4149名患者纳入第三级护理ICCU (2019年7月 - 2023年7月).
根据hs-cTnI峰值水平 (从<100 ng/L到≥100,000 ng/L) 分类为五组.
一年全因死亡率作为主要结局,使用调整后的考克斯模型进行分析.

主要成果:

与最低组相比,高峰hs-cTnI≥100,000 ng/L的患者在一年内死亡的可能性增加了56%.
峰值hs-cTnI水平≥100,000 ng/L对于心肌梗塞 (97.4%),特别是STEMI (87.5%) 的高度特异性.
升高的hs-cTnI与NSTEMI患者 (HR 7.62) 的较高死亡率有关,但与STEMI患者 (HR 1.04) 的较高死亡率无关.

结论:

峰值hs-cTnI水平≥100,000 ng/L是ICCU患者一年死亡率增加的重要预测因素.
这些高水平往往意味着大型心肌梗塞.
在STEMI与NSTEMI中hs-cTnI的不同预后影响需要进一步调查.

关键词:

在ACS ACS中使用.生物标志物生物标志物国际海事联盟国际海事联盟 (ICCU)托罗邦尼 (Troponin) 是一种可怕的药物.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...